An efficient synthesis of risperidonevia stille reaction: Antipsychotic, 5-HT2, and dopamine-D2-antagonist

2005 ◽  
Vol 28 (9) ◽  
pp. 1019-1022 ◽  
Author(s):  
Dong-myung Kim ◽  
Min-Seok Kang ◽  
Jeong Sook Kim ◽  
Jin-Hyun Jeong
Keyword(s):  
Stille Reaction ◽  
Efficient Synthesis ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist

Animal Pharmacology of Raclopride, a Selective Dopamine D2 Antagonist

1989 ◽  
pp. 123-130 ◽  
Author(s):  
H. Hall ◽  
S. O. Ögren ◽  
C. Köhler ◽  
O. Magnusson
Keyword(s):  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine ◽  
Animal Pharmacology

Object recognition impairment and rescue by a dopamine D2 antagonist in hyperdopaminergic mice

2016 ◽  
Vol 308 ◽  
pp. 211-216 ◽  
Author(s):  
Arthur S.C. França ◽  
Larissa Muratori ◽  
George Carlos Nascimento ◽  
Catia Mendes Pereira ◽  
Sidarta Ribeiro ◽  
...  
Keyword(s):  
Object Recognition ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist

Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood

2006 ◽  
Vol 85 (1-3) ◽  
pp. 222-231 ◽  
Author(s):  
H SAEEDI ◽  
G REMINGTON ◽  
B CHRISTENSEN
Keyword(s):  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist

The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial

1991 ◽  
Vol 4 (3) ◽  
pp. 311-312
Author(s):  
A.G. Awad ◽  
Y.D. Lapierre ◽  
N.P.V. Nair ◽  
P. Beaudry ◽  
B. Saxena ◽  
...  
Keyword(s):  
Multicenter Trial ◽  
Acute Schizophrenia ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine

Remoxipride — A selective dopamine D2 antagonist in the treatment of acute schizophrenia: a Canadian multicentre clinical trial

1990 ◽  
Vol 3 (1) ◽  
pp. 45 ◽  
Author(s):  
A.G. Awad ◽  
Y.D. Lapierre ◽  
N.P.V. Nair ◽  
P. Beaudry ◽  
B. Saxena ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Multicentre Clinical Trial ◽  
Acute Schizophrenia ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine

The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors

Neuroscience ◽  
1994 ◽  
Vol 61 (2) ◽  
pp. 269-283 ◽  
Author(s):  
S.O. Ögren ◽  
L. Rosén ◽  
K. Fuxe
Keyword(s):  
D2 Receptors ◽  
Dopamine D2 Receptors ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist
Sign in / Sign up

Export Citation Format

Share Document